Clinical trial
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention ("Adaptive Trial")
NCT02896712 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention ("Adaptive Trial")
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 18, 2016
- Completion date
- September 13, 2021
- Enrollment
- 118 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.